This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $400,000
STARS: Surveillance and Testing for Antiviral Resistance in SARS-CoV-2
CIHR · 2022 · Co-investigator
- $499,276
SARS-CoV-2 variants under investigation (VUIs) and variants of concern (VOCs); phenotyping gaps in transmission, reinfection and response to medical countermeasures
CIHR · 2021 · Co-investigator
- $100,000
SARS-CoV-2 genotype-dependent pathogenesis and transmission
CIHR · 2020 · Principal investigator
STARS: Surveillance and Testing for Antiviral Resistance in SARS-CoV-2
Principal investigators: Kozak, Robert A; McGeer, Allison J
Keywords: Antiviral Resistance; Drug Efficacy; Laboratory Testing; Transmission; Whole-Genome Sequencing
SARS-CoV-2 variants under investigation (VUIs) and variants of concern (VOCs); phenotyping gaps in transmission, reinfection and response to medical countermeasures
Principal investigators: Mubareka, Samira
Keywords: Animal Model; Congregate Setting; Genomics; Pathogenesis; Reinfection; Sars-Cov-2; Transmission; Vaccination; Variants Of Concern (Voc)
SARS-CoV-2 genotype-dependent pathogenesis and transmission
Principal investigators: Mubareka, Samira; Mcarthur, Andrew G
Keywords: Animal Models; Bioaerosols; Genomics; Organoids; Pathogenesis; Sars-Cov-2; Transmission
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.